Illuminator for pathogen reduction
Ended Purchase Order Awarded Last action
- Contract number
- 36C25220P0820
- Awardee
-
Cerus Corporation UEI KJJQRRLY2FL5
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $68,591
Award facts
- Opportunity
-
- 6515--Notice of Intent to Sole Source Illuminator for Pathogen Reduction Intercept brand name only Special Notice · 36C25220Q0697 · Posted Jul 14, 2020
- 6515--Illuminator for Pathogen Reduction for the Captain James A. Lovell FHCC in North Chicago, Illinois. Award Notice · Posted Aug 10, 2020
- Contract value 83% obligated
-
- $68,591.00 Current, with exercised options
- $82,389.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Concord, CA 94520, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $6,896 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $6,695 | |
| Other Administrative Action | $0 | |
| Original award | $55,000 |
About this award
This is a firm-fixed price purchase order awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, to Cerus Corporation, a biomedical company specializing in blood safety technologies and pathogen reduction systems. The $82,389 contract is for the supply of INTERCEPT Illuminator 60 Hz systems and associated maintenance services. The illuminators are essential components of Cerus Corporation's proprietary INTERCEPT Blood System, which uses riboflavin and ultraviolet light to inactivate pathogens in blood products. This sole-source award was made under FAR 13.106-1(b) without any set-aside designation, as Cerus Corporation is the only responsible source for the required items. The contract has an ultimate completion date of September 22, 2024 and supports the agency's efforts to reduce the risk of transfusion-transmitted infections in blood products used by military and civilian healthcare facilities.
Quick answers
Who was awarded contract 36C25220P0820?
36C25220P0820 was awarded to Cerus Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 10, 2020.
How much is contract 36C25220P0820 worth?
The government has obligated $68,591 on 36C25220P0820. Its potential value, with all options, is $82,389.
Was contract 36C25220P0820 competed?
The extent of competition for 36C25220P0820 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award